-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Plenary Introducer

Program: General Sessions
Session: Plenary Scientific Session
Sunday, December 10, 2023, 2:00 PM-4:00 PM

Peter M. Voorhees, MD

Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC

Disclosures: Voorhees: Abbvie: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; BMS: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: Data Safety and Monitoring; GSK: Consultancy, Research Funding; Janssen: Consultancy, Research Funding; Karyopharm: Consultancy; Regeneron: Consultancy; Nervianos Medical Sciences: Research Funding; Sanofi: Membership on an entity's Board of Directors or advisory committees.

See more of: Plenary Scientific Session
See more of: General Sessions
<< Previous Presentation | Next Presentation >>